...
首页> 外文期刊>International Journal of Pharmaceutics >A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.
【24h】

A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.

机译:一种连续且高效的静态混合过程,用于纳米颗粒的水溶性药物纳米粒子的抗溶剂沉淀。

获取原文
获取原文并翻译 | 示例
           

摘要

Rapid and homogeneous mixing of the solvent and antisolvent is critical to achieve submicron drug particles by antisolvent precipitation technique. This work aims to develop a continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs with spironolactone as a model drug. Continuous antisolvent production of drug nanoparticles was carried out with a SMV DN25 static mixer comprising 6-18 mixing elements. The total flow rate ranged from 1.0 to 3.0 L/min while the flow rate ratio of solvent to antisolvent was maintained at 1:9. It is found that only 6 mixing elements were sufficient to precipitate the particles in the submicron range. Increasing the number of elements would further reduce the precipitated particle size. Increasing flow rate from 1.0 to 3.0 L/min did not further reduce the particle size, while higher drug concentrations led to particle size increase. XRD and SEM results demonstrated that the freshly precipitated drug nanoparticles are in the amorphous state, which would, in presence of the mixture of solvent and antisolvent, change to crystalline form in short time. The lyophilized spironolactone nanoparticles with lactose as lyoprotectant possessed good redispersibility and showed 6.6 and 3.3 times faster dissolution rate than that of lyophilized raw drug formulation in 5 and 10 min, respectively. The developed static mixing process exhibits high potential for continuous and large-scale antisolvent precipitation of submicron drug particles.
机译:溶剂和抗溶剂的快速和均匀混合对于通过抗溶解沉淀技术实现亚微米药物颗粒至关重要。这项工作旨在开发一种连续且高效的静态混合过程,用于用螺内酯作为模型药物的含水溶解药物的纳米颗粒的抗溶解沉淀。用包含6-18个混合元件的SMV DN25静态混合器进行连续的防溶剂产生药物纳米颗粒。总流量范围为1.0至3.0升/分钟,而溶剂对抗溶剂的流量比保持在1:9。发现只有6个混合元素足以沉淀亚微米范围内的颗粒。增加元素的数量将进一步降低沉淀的粒度。从1.0到3.0 L / min的流速增加流速并未进一步降低粒径,而较高的药物浓度导致粒度增加。 XRD和SEM结果表明,新鲜沉淀的药物纳米颗粒处于无定形状态,即在溶剂和抗溶剂的混合物存在下,在短时间内变为结晶形式。冻干的螺旋酮纳米酮纳米酮,乳糖作为催乳素,分别具有良好的重新分散性,并显示出比溶解率的速度快于5-10分钟的溶解率快6.6和3.3倍。开发的静态混合过程具有高潜力的亚微米药物颗粒的连续和大规模的抗溶解沉淀。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号